FdaApplication
NDA 202212
Identifiers
- fda_app_no: NDA202212
Properties
| Property | Value |
|---|---|
| applicant_name | CIPLA LIMITED |
| application_type | NDA |
Products (2)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| NEVIRAPINE | NEVIRAPINE | 50MG | TABLET, FOR SUSPENSION;ORAL |
| NEVIRAPINE | NEVIRAPINE | 100MG | TABLET, FOR SUSPENSION;ORAL |
2 products